[Outcome of haploidentical hematopoietic stem cell transplantation for aggressive natural killer cell leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):591-593. doi: 10.3760/cma.j.issn.0253-2727.2021.07.010.

[Article in Chinese]

Authors

J Xia¹, S N Chen¹, Z M Jin¹, X W Tang¹, F Chen¹, X Ma¹, M Miao¹, D P Wu¹

Affiliation

¹ National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

PMID: 34455747
PMCID: PMC8408496
DOI: 10.3760/cma.j.issn.0253-2727.2021.07.010

No abstract available

MeSH terms

Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Large Granular Lymphocytic*
Transplantation Conditioning
Treatment Outcome

Grants and funding

基金项目：国家重点研发计划（2019YFC0840604）；江苏省重点研发计划（BE2019798）；江苏省科教强卫工程-临床医学中心（YXZXA2016002）